Capital Research Global Investors
Position in WGS — GeneDx Holdings Corp.
CIK 1422848
Los Angeles, CA
Position in WGS
as of Mar 31, 2026
· filed May 13, 2026
Position Value
$9,700,752
-$6,253,187 QoQ
Shares Held
151,055
+23.1% QoQ
Ownership
0.509%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Dec 2025
2 quarters on record
Voting authority
Sole 100.ToString("F0")%
Shared 0.ToString("F0")%
None 0.ToString("F0")%
Common Shares in WGS Over Time
Shares Held
Position Value (USD)
Position in Diagnostics & Research
Healthcare · as of Mar 31, 2026Capital Research Global Investors holds $4,311,389,109 across 6 Diagnostics & Research names. WGS ranks #4 (0.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | TMO |
Thermo Fisher Scientific Inc.
|
4,414,621 | $2,169,918,660 | |
| 2 | DHR |
Danaher Corp /De/
|
8,897,773 | $1,687,017,760 | |
| 3 | IDXX |
Idexx Laboratories Inc /De
|
781,345 | $439,029,942 | |
| 4 | WGS |
GeneDx Holdings Corp.
This page
|
151,055 | $9,700,752 | |
| 5 | QGEN |
Qiagen N.V.
|
119,998 | $4,804,719 | |
| 6 | RVTY |
Revvity, Inc.
|
10,470 | $917,276 |
All Filings in WGS
Export CSV
2 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $9,700,752 | 151,055 | Shares | Defined | 2026-05-13 | |
| 2025-12-31 | $15,953,939 | 122,666 | Shares | Defined | 2026-02-11 | |
| No filing history on record for this holder in this stock. | ||||||